Stock Analysis·← Pickers

DHR

DHR is currently in a range/mixed trend, above the 50-day MA but below the 200-day MA. RSI is at 64.4, with 1/3 trend checks passing.

Price
$200.79
2026-07-16
Trend score
1/3
Range / Mixed
RSI (14)
64.4
Neutral
Price above MA50Price above MA200MA50 above MA200
Change stock
Search another ticker to view its stock analysis page.
Chart View

DHR with MA50 and MA200

242.1222.0202.0181.9161.907/3110/2401/2204/1707/15
DHR2025-07-312026-07-15
PriceMA50MA200
Technical Indicators

Key levels & signals

MA50
$181.50+10.63% vs price
MA200
$204.26-1.70% vs price
RSI (14)
64.4Neutral zone
MACD Signal
BullishMomentum above signal
Macro Support
$180.03–$185.507.6% below price · 3 touches
Support Quality
3 touches1.2× zone volume
Chart Summary
Trend summary for DHR

DHR currently looks more uncertain than directional, with a fairly mixed technical picture. The latest available price is $200.79, and 1 of 3 core trend checks are currently passing. Price is trading above the 50-day moving average by 10.6% and below the 200-day moving average by 1.7%.

Momentum and stretch context

DHR currently has an RSI reading of 64.4, which leans mildly positive without looking too stretched. In other words, momentum is supportive, but not yet extreme enough to dominate the entire chart read.

What traders may watch next

This page is designed to help you quickly understand what the DHR chart looks like before opening the full dashboard. The aim is not to tell you what to buy or sell, but to make it easier to judge whether the stock is trending cleanly, becoming stretched, or simply moving in a more awkward range.

Company profile

About Danaher Corporation

Danaher Corporation is a diversified global technology and science company that specializes in developing, manufacturing, and distributing a wide array of professional, medical, industrial, and commercial products and services across the world. The organization is structured into three primary operating segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. Within the Life Sciences segment, Danaher provides advanced instrumentation and solutions crucial for scientific research and development. This encompasses equipment like mass spectrometers, flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization tools, and microscopes, alongside genomics consumables and technologies vital for Gene and Cell Therapy. Additionally, it delivers bioprocess technologies, consumables, and related services, as well as sophisticated filtration, separation, and purification systems. Its diverse clientele includes pharmaceutical, biopharmaceutical, food and beverage, medical, and life sciences companies, in addition to universities, medical schools, research institutions, and various industrial manufacturers. The Diagnostics segment is dedicated to furnishing essential tools for healthcare. Its offerings range from comprehensive systems for chemistry, immunoassay, microbiology, and automation to products for hematology, molecular, acute care, and pathology diagnostics. This segment equips hospitals, physicians' offices, reference laboratories, and other critical care settings with clinical instruments, reagents, consumables, software, and support services for accurate patient diagnosis and management. The Environmental & Applied Solutions segment addresses a broad spectrum of industrial and resource management requirements. It supplies instrumentation, consumables, software, services, and disinfection systems critical for the analysis, treatment, and management of various water types—including ultra-pure, potable, industrial, waste, ground, source, and ocean water—across residential, commercial, industrial, and natural resource applications. Furthermore, this segment delivers instruments, software, services, and consumables tailored for color and appearance management, packaging design and quality assurance, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. Established in 1969, the company was initially known as Diversified Mortgage Investors, Inc., before officially rebranding as Danaher Corporation in 1984. Its corporate headquarters are located in Washington, D.C.

Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Rainer Blair
Employees
61,000
Market cap
$142.11B
Beta
0.82
52-week range
$160.93 – $242.80
Dividend
Yes · $1.44
Exchange
NYSE
Country
US
IPO date
29 Dec 1978
ISIN
US2358511028
CUSIP
235851102
Company profile data from Financial Modeling Prep. DHR listed on NYSE.
Learn More

Learn the indicators behind this page

Explore More

More stock opportunities

FAQ

Common questions about DHR

Is this page a buy or sell recommendation?

No. This page is designed to help you review chart structure, momentum and technical context more quickly, but it is not personal financial advice.

Why can a stock look bullish and overbought at the same time?

Strong trending stocks can still become stretched in the short term. That is why trend traders and dip buyers can read the same chart differently.

What should I do next after reading this page?

Open the full dashboard, review the chart in more detail, compare indicators, and decide whether the setup still makes sense within your own process.